BG103850A - The application of secreting vector for fertility control by peroral vaccination - Google Patents

The application of secreting vector for fertility control by peroral vaccination

Info

Publication number
BG103850A
BG103850A BG103850A BG10385099A BG103850A BG 103850 A BG103850 A BG 103850A BG 103850 A BG103850 A BG 103850A BG 10385099 A BG10385099 A BG 10385099A BG 103850 A BG103850 A BG 103850A
Authority
BG
Bulgaria
Prior art keywords
vaccination
peroral
application
fertility control
secreting
Prior art date
Application number
BG103850A
Other languages
Bulgarian (bg)
Inventor
Peter Donner
Werner Goebel
Andreas Demuth
Ivaylo Gentschev
Jurgen Hess
Stefan Kaufmann
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of BG103850A publication Critical patent/BG103850A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to a method for fertility control, in particular by attenuated strains for vaccination. Different express systems are applied for opening opportunities for provoking desired MHCII/CD4 or MHCI/CD8 immune response. 6 claims, 12 figures
BG103850A 1997-05-07 1999-11-02 The application of secreting vector for fertility control by peroral vaccination BG103850A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19720761A DE19720761A1 (en) 1997-05-07 1997-05-07 Process for the synthesis and secretion of proteins or protein fragments suitable for contraception by attenuated Salmonella or another Gram-negative attenuated vaccine strain to produce an oral vaccination
PCT/EP1998/002679 WO1998050067A2 (en) 1997-05-07 1998-05-07 Use or a secretion vector for fertility control by oral vaccination

Publications (1)

Publication Number Publication Date
BG103850A true BG103850A (en) 2000-05-31

Family

ID=7829783

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103850A BG103850A (en) 1997-05-07 1999-11-02 The application of secreting vector for fertility control by peroral vaccination

Country Status (18)

Country Link
EP (1) EP1015023A1 (en)
JP (1) JP2002501507A (en)
KR (1) KR20010012257A (en)
CN (1) CN1255067A (en)
AU (1) AU7910798A (en)
BG (1) BG103850A (en)
BR (1) BR9809244A (en)
CA (1) CA2288602A1 (en)
DE (1) DE19720761A1 (en)
EE (1) EE9900516A (en)
HU (1) HUP0002752A2 (en)
IL (1) IL132521A0 (en)
IS (1) IS5199A (en)
NO (1) NO995429L (en)
PL (1) PL336786A1 (en)
SK (1) SK151799A3 (en)
TR (1) TR199902671T2 (en)
WO (1) WO1998050067A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10206325A1 (en) * 2002-02-14 2003-09-04 Medinnova Ges Med Innovationen Coated microorganism
US6989160B2 (en) * 2002-03-19 2006-01-24 Council Of Scientific And Industrial Research Therapeutic/edible compositions comprising herbal ingredients and methods for treating hyperglycemia
BRPI0609675A2 (en) * 2005-05-12 2011-10-18 Ajinomoto Kk method for producing a protein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2096529C (en) * 1990-11-21 2003-01-21 Roy Curtiss, Iii Recombinant avirulent salmonella antifertility vaccines
US5480799A (en) * 1993-12-10 1996-01-02 The University Of North Carolina At Chapel Hill Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope

Also Published As

Publication number Publication date
AU7910798A (en) 1998-11-27
SK151799A3 (en) 2000-06-12
IS5199A (en) 1999-09-28
NO995429L (en) 2000-01-07
JP2002501507A (en) 2002-01-15
WO1998050067A3 (en) 2000-06-29
NO995429D0 (en) 1999-11-05
EE9900516A (en) 2000-06-15
CN1255067A (en) 2000-05-31
EP1015023A1 (en) 2000-07-05
CA2288602A1 (en) 1998-11-12
DE19720761A1 (en) 1998-11-12
WO1998050067A2 (en) 1998-11-12
WO1998050067A9 (en) 1999-03-25
IL132521A0 (en) 2001-03-19
TR199902671T2 (en) 2000-09-21
HUP0002752A2 (en) 2000-12-28
PL336786A1 (en) 2000-07-17
KR20010012257A (en) 2001-02-15
BR9809244A (en) 2000-06-27

Similar Documents

Publication Publication Date Title
CA2217178A1 (en) Vaccines containing a saponin and a sterol
GB2322801B (en) Vaccine compositions for intranasal administration comprising chitosan and use thereof
HK1052725B (en) Altered strain of the modified vaccinia virus ankara (mva)
NZ532665A (en) Neisseria meningitidis antigens and compositions
GB9808327D0 (en) Antidiotypic compounds
TW340105B (en) Water-repellent plaster compositions and process for the water-repellent treatment of plaster
GR3035548T3 (en) Controlled release of drugs delivered by sublingual or buccal administration
WO2001035991A3 (en) Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof
NZ512011A (en) Improved saponin adjuvant compositions and methods relating thereto
WO1999004750A3 (en) Use of polymers containing polysiloxane for cosmetic formulations
WO2002077761A3 (en) Method and system for offering debt recovery products to a customer
EP1335023A3 (en) Methods and reagents for vaccination which generate a CD8 T cell immune response
BG104511A (en) Spheroids, preparation method and pharmaceutical compositions
TW233242B (en)
MX9600770A (en) Conditioning shampoo containing insoluble, non-volatile silicone.
BG103850A (en) The application of secreting vector for fertility control by peroral vaccination
EP0835131A4 (en) cDNA CLONE FOR SOUTH AFRICAN ARBOVIRUS NO. 86
NZ335050A (en) Helicobacter pylori live vaccine
AUPO007396A0 (en) Ebv ctl epitopes
MY117253A (en) Novel colloid dispersion mixtures as protective colloid for aqueous emulsion polymerization, processes for preparing them and their use
MY106240A (en) Novel strains of bacillus thuringiensis, methods for the preparation thereof and use thereof controlling insecis and protecting plants from insects attack
IL114141A0 (en) Method for preparing cloud stable extract
CA2210294A1 (en) Immunogenic compositions containing recombinant attenuated poxviruses expressing htlv antigens
AU2000273396A1 (en) Hla binding peptides and their uses
ES2124134A1 (en) System for combating forest fires